Retail News CRM

Tag: telehealth

  • Doctor Anywhere Suffers Data Breach Exposing Identification and Bank Records

    Doctor Anywhere Suffers Data Breach Exposing Identification and Bank Records

    Telehealth provider Doctor Anywhere announced on Friday evening, Nov 6, that an unauthorized third party breached its systems and accessed users’ personal information.

    The intrusion, which the Singapore firm discovered on Oct 29, compromised customer names, email addresses, dates of birth, emergency contacts, bank account numbers, identity card digits and passport details.

    Doctor Anywhere stated that investigations have found no evidence showing passwords, account login credentials, payment card details or scanned identity card photos were compromised, though it has not disclosed how many users were affected.

    Corporate Benefits Exposure Through Adept Health

    Part of the compromised data involves corporate accounts held through Adept Health, a Doctor Anywhere subsidiary that manages employee benefits programs for corporate clients across Singapore. The platform keeps select personal records of corporate members inside its central architecture to administer employer coverage and process claims.

    Digital health providers across Southeast Asia rely on corporate medical coverage contracts to generate recurring cash flow alongside direct-to-consumer video doctor consultations. A breach across employer benefits architecture creates immediate legal and compliance questions for human resource directors managing corporate health data.

    Fixes Deployed with Ensign InfoSecurity

    The company engaged cybersecurity and digital forensics firm Ensign InfoSecurity to examine the network intrusion and apply corrective patches. Ensign confirmed that the discovered vulnerabilities were locked down and validated the fixes on Oct 30, according to the health operator.

    Medical treatment records remained untouched throughout the incident, the provider said following initial network scans. Its digital platform, outpatient clinics and walk-in facilities remain fully operational while customer notifications continue.

    Regulatory Reports and System Review

    Doctor Anywhere reported the breach to the Personal Data Protection Commission and lodged a formal report with the Singapore Police Force. The healthcare group must now handle regulatory inquiries under local personal data protection laws while notifying affected corporate accounts and private users.

    Telehealth and app-based clinic operators throughout the region face tighter scrutiny over data boundaries as medical services merge with insurance administration and electronic payment processing. Doctor Anywhere faces the immediate task of satisfying corporate clients on data segregation while keeping core clinic visits running on schedule.

  • Hims Enters Australia with Pilot Rebrand in $1 Billion Global Push

    Hims Enters Australia with Pilot Rebrand in $1 Billion Global Push

    Hims & Hers Health has launched operations in Australia by rebranding local men’s clinic Pilot, setting its sights on a 1 billion dollar international annual revenue target within three years.

    The transition gives the New York-listed group immediate access to a domestic telehealth market projected to reach 2.56 billion dollars by 2034. It also establishes the company’s first operating foothold in the Asia-Pacific region following its takeover of Sydney-based parent Eucalyptus earlier this year.

    How the Transition Operates

    Existing Pilot patients will transfer directly to the Hims platform, keeping their current treatment plans and practitioner links. Roughly 30 percent of the platform’s patient base lives in regional and rural Australia, where physical clinic access remains thin and appointment wait times run long.

    Former Eucalyptus chief executive Tim Doyle leads the international division as senior vice president, running Australian operations alongside country general manager Gus Wood. Dr Matt Vickers serves as chief medical officer for the local entity to oversee clinical governance and domestic regulatory standards.

    Pilot proved that Australian men want a different model of healthcare: one that is proactive, personal, and built around their lives.

    The Read Across for Digital Health

    Consolidating Eucalyptus under the core Hims identity shows how direct-to-consumer health brands are moving away from multi-brand regional stables toward single global flags. Maintaining separate platforms in every territory drives up customer acquisition costs and fragments marketing spend. By putting its primary brand on Australian screens, Hims can funnel global brand marketing and technology infrastructure straight into a market with high average revenue per user.

    The risk lies in consumer attachment and regulatory scrutiny. Digital health platforms in Australia face strict advertising rules around prescription treatments and compounding pharmacies, alongside tight supervision from medical boards. Pilot built significant local recognition, and erasing the name risks alienating repeat customers if the migration disrupts prescription delivery or doctor consultations.

    The Steps That Led Here

    Hims & Hers completed its buyout of Eucalyptus earlier this year, securing established patient networks in Australia and the United Kingdom. Eucalyptus had originally built discrete vertical brands including Pilot for men, Kin for fertility, and Software for dermatology, proving out direct-to-door medicine across Australasia before selling to the San Francisco operator.

    Market watchers will track whether Hims rebrands the remaining Eucalyptus product lines across women’s health and dermatology, and whether Australian patient numbers keep the company on course for its 1 billion dollar international revenue goal by 2029.

  • Hims & Hers Rolls Out Weight-Loss and Prescription Platform in Australia

    Hims & Hers Rolls Out Weight-Loss and Prescription Platform in Australia

    Telehealth group Hims & Hers has launched branded GLP-1 weight-loss drugs and prescription treatments in Australia, chasing a global revenue target of US$6.5 billion by 2030.

    The rollout follows the completed acquisition of Sydney-based digital health firm Eucalyptus, which gave the US provider control of local men’s telehealth brand Pilot. Australian patients can now access treatments for sexual health, cholesterol and weight management directly through the combined digital channel.

    Integration of Pilot and Juniper

    Existing Pilot clinicians are shifting directly over to the Hims platform. A spokesperson for the company confirmed that the weight-loss catalogue includes access to branded GLP-1 medications, mirroring its US lineup of treatments such as Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.

    Former Eucalyptus chief executive Tim Doyle, who now serves as senior vice president at Hims & Hers, will oversee the Australian rollout. The company plans to bundle consultations and products that consumers previously bought as separate transactions, focusing on suburban and regional areas where physical access to specialists is limited.

    Digital health platforms across the Asia-Pacific region are consolidating fast to capture soaring consumer demand for metabolic care and discreet direct-to-consumer treatments. Local pharmacy operators face stiffer competition as international platforms buy up homegrown startups rather than building customer rosters from scratch.

    International Expansion and Margins

    Expanding across foreign markets has lifted monthly revenue per subscriber by 21 per cent year-on-year. That top-line gain comes with a cost: management told investors during its second-quarter earnings call that gross profit margins will stay below historical levels while international operations scale.

    The Australian launch builds on the 2025 purchase of London-based Zava, which distributes weight-loss drugs across the UK, Germany, France and Ireland. Next on the Australian schedule is the launch of its dedicated women’s health service through Eucalyptus brand Juniper before the end of the year.

  • APAC telehealth market to hit $1.79b by 2020

    APAC telehealth market to hit $1.79b by 2020

    Increased usage of mobile and broadband internet in the Asia-Pacific region are driving the adoption of new healthcare delivery models, new analysis from Frost & Sullivan shows.

    The research indicates that telehealth is helping to address challenges like rising costs, increasing incidence of chronic and infectious diseases, and ageing populations.

    The telehealth market in the region, which includes telemedicine, remote patient monitoring (RPM) and mobile health (mHealth), is estimated to reach $1.79 billion in 2020 from $1.02 billion in 2015, growing at a compound annual growth rate (CAGR) of 12%.

    Telehealth is helping to optimize costs, improve resource efficiency in primary care and aged care, drive medical tourism, and engage the young and healthy population in early intervention, prevention and wellness, the report finds.

    Governments in Asia-Pacific are also playing a significant role in driving technology development and adoption by investing in infrastructure, developing telehealth and eHealth roadmaps and creating policies that directly or indirectly attract investment in health technology.

    At a country level, telecoms are also working with governments to help build Smart Cities and Smart Nation infrastructure with telehealth as a key area almost always included in a Smart City plan. Such projects allow vendors to expand their presence and penetration into strategic industries and also bring in their experience and expertise from other regions to Asia-Pacific.

    However, while the demand for telehealth technologies is strong, vendors and healthcare providers in the region, have not been able to grow their businesses to the aspired scale and volume.

    “A number of pilots have failed to reach commercialization due to poor clinician adoption, an unfavourable regulatory environment and the lack of clarity around payment models,” said Natasha Gulati, Transformational Health Industry Manager, Frost & Sullivan Asia-Pacific.

    “Establishing a sustainable business model is the single most critical business challenge for market participants today and we are constantly working with our clients to introduce business model innovation in this domain,” she said.

    The report concluded that the region now needs to explore change management strategies that will drive adoption, especially among providers.

    Lees ook: